Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
MSI-H/dMMR Solid Tumors
Chongqing, Chongqing Municipality
MSI-H/dMMR Solid Tumors Clinical Trials in Chongqing, Chongqing Municipality
1 recruiting
Chongqing, Chongqing Municipality, China
Showing
1–1
of
1
trials
Recruiting
Phase 2
Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors
MSI-H/dMMR Solid Tumors
BeiGene
200 enrolled
29 locations
NCT03736889
Feedback